nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—ALB—Fluorouracil—urinary bladder cancer	0.221	0.645	CbGbCtD
Gatifloxacin—ALB—Methotrexate—urinary bladder cancer	0.122	0.355	CbGbCtD
Gatifloxacin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000633	0.000964	CcSEcCtD
Gatifloxacin—Dysuria—Epirubicin—urinary bladder cancer	0.000631	0.00096	CcSEcCtD
Gatifloxacin—Neutropenia—Epirubicin—urinary bladder cancer	0.000631	0.00096	CcSEcCtD
Gatifloxacin—Dizziness—Thiotepa—urinary bladder cancer	0.00063	0.000959	CcSEcCtD
Gatifloxacin—Stomatitis—Methotrexate—urinary bladder cancer	0.000626	0.000954	CcSEcCtD
Gatifloxacin—Urticaria—Fluorouracil—urinary bladder cancer	0.000626	0.000953	CcSEcCtD
Gatifloxacin—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000625	0.000951	CcSEcCtD
Gatifloxacin—Dysphagia—Doxorubicin—urinary bladder cancer	0.000624	0.00095	CcSEcCtD
Gatifloxacin—Asthma—Doxorubicin—urinary bladder cancer	0.000624	0.00095	CcSEcCtD
Gatifloxacin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000623	0.000948	CcSEcCtD
Gatifloxacin—Sweating—Methotrexate—urinary bladder cancer	0.000616	0.000938	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000616	0.000937	CcSEcCtD
Gatifloxacin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000615	0.000937	CcSEcCtD
Gatifloxacin—Paraesthesia—Etoposide—urinary bladder cancer	0.000614	0.000935	CcSEcCtD
Gatifloxacin—Haematuria—Methotrexate—urinary bladder cancer	0.000613	0.000933	CcSEcCtD
Gatifloxacin—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000612	0.000931	CcSEcCtD
Gatifloxacin—Dyspnoea—Etoposide—urinary bladder cancer	0.00061	0.000929	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000608	0.000926	CcSEcCtD
Gatifloxacin—Somnolence—Etoposide—urinary bladder cancer	0.000608	0.000926	CcSEcCtD
Gatifloxacin—Epistaxis—Methotrexate—urinary bladder cancer	0.000606	0.000923	CcSEcCtD
Gatifloxacin—Vomiting—Thiotepa—urinary bladder cancer	0.000606	0.000922	CcSEcCtD
Gatifloxacin—Rash—Thiotepa—urinary bladder cancer	0.000601	0.000914	CcSEcCtD
Gatifloxacin—Dermatitis—Thiotepa—urinary bladder cancer	0.0006	0.000913	CcSEcCtD
Gatifloxacin—Headache—Thiotepa—urinary bladder cancer	0.000597	0.000908	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000596	0.000908	CcSEcCtD
Gatifloxacin—Decreased appetite—Etoposide—urinary bladder cancer	0.000595	0.000906	CcSEcCtD
Gatifloxacin—Body temperature increased—Cisplatin—urinary bladder cancer	0.00059	0.000899	CcSEcCtD
Gatifloxacin—Stomatitis—Epirubicin—urinary bladder cancer	0.000586	0.000892	CcSEcCtD
Gatifloxacin—Constipation—Etoposide—urinary bladder cancer	0.000585	0.000891	CcSEcCtD
Gatifloxacin—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000584	0.00089	CcSEcCtD
Gatifloxacin—Dysuria—Doxorubicin—urinary bladder cancer	0.000583	0.000888	CcSEcCtD
Gatifloxacin—Neutropenia—Doxorubicin—urinary bladder cancer	0.000583	0.000888	CcSEcCtD
Gatifloxacin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00058	0.000884	CcSEcCtD
Gatifloxacin—Hepatitis—Methotrexate—urinary bladder cancer	0.000577	0.000878	CcSEcCtD
Gatifloxacin—Sweating—Epirubicin—urinary bladder cancer	0.000576	0.000878	CcSEcCtD
Gatifloxacin—Asthenia—Gemcitabine—urinary bladder cancer	0.000575	0.000875	CcSEcCtD
Gatifloxacin—Haematuria—Epirubicin—urinary bladder cancer	0.000573	0.000873	CcSEcCtD
Gatifloxacin—Pharyngitis—Methotrexate—urinary bladder cancer	0.000572	0.000872	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.00057	0.000867	CcSEcCtD
Gatifloxacin—Epistaxis—Epirubicin—urinary bladder cancer	0.000567	0.000864	CcSEcCtD
Gatifloxacin—Pruritus—Gemcitabine—urinary bladder cancer	0.000567	0.000863	CcSEcCtD
Gatifloxacin—Nausea—Thiotepa—urinary bladder cancer	0.000566	0.000861	CcSEcCtD
Gatifloxacin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000564	0.000858	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000563	0.000857	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000559	0.000852	CcSEcCtD
Gatifloxacin—Pruritus—Fluorouracil—urinary bladder cancer	0.000557	0.000849	CcSEcCtD
Gatifloxacin—Visual impairment—Methotrexate—urinary bladder cancer	0.000556	0.000846	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000552	0.00084	CcSEcCtD
Gatifloxacin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00055	0.000838	CcSEcCtD
Gatifloxacin—Bradycardia—Epirubicin—urinary bladder cancer	0.00055	0.000837	CcSEcCtD
Gatifloxacin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000548	0.000835	CcSEcCtD
Gatifloxacin—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000545	0.00083	CcSEcCtD
Gatifloxacin—Urticaria—Etoposide—urinary bladder cancer	0.000543	0.000828	CcSEcCtD
Gatifloxacin—Stomatitis—Doxorubicin—urinary bladder cancer	0.000542	0.000826	CcSEcCtD
Gatifloxacin—Abdominal pain—Etoposide—urinary bladder cancer	0.000541	0.000823	CcSEcCtD
Gatifloxacin—Body temperature increased—Etoposide—urinary bladder cancer	0.000541	0.000823	CcSEcCtD
Gatifloxacin—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000541	0.000823	CcSEcCtD
Gatifloxacin—Hepatitis—Epirubicin—urinary bladder cancer	0.00054	0.000822	CcSEcCtD
Gatifloxacin—Eye disorder—Methotrexate—urinary bladder cancer	0.000539	0.000821	CcSEcCtD
Gatifloxacin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000539	0.000821	CcSEcCtD
Gatifloxacin—Tinnitus—Methotrexate—urinary bladder cancer	0.000538	0.000819	CcSEcCtD
Gatifloxacin—Asthenia—Cisplatin—urinary bladder cancer	0.000536	0.000816	CcSEcCtD
Gatifloxacin—Pharyngitis—Epirubicin—urinary bladder cancer	0.000536	0.000816	CcSEcCtD
Gatifloxacin—Sweating—Doxorubicin—urinary bladder cancer	0.000533	0.000812	CcSEcCtD
Gatifloxacin—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000532	0.00081	CcSEcCtD
Gatifloxacin—Haematuria—Doxorubicin—urinary bladder cancer	0.00053	0.000808	CcSEcCtD
Gatifloxacin—Epistaxis—Doxorubicin—urinary bladder cancer	0.000525	0.000799	CcSEcCtD
Gatifloxacin—Dizziness—Fluorouracil—urinary bladder cancer	0.000521	0.000793	CcSEcCtD
Gatifloxacin—Visual impairment—Epirubicin—urinary bladder cancer	0.00052	0.000792	CcSEcCtD
Gatifloxacin—Chills—Methotrexate—urinary bladder cancer	0.000518	0.000788	CcSEcCtD
Gatifloxacin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000511	0.000778	CcSEcCtD
Gatifloxacin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00051	0.000777	CcSEcCtD
Gatifloxacin—Vomiting—Gemcitabine—urinary bladder cancer	0.000509	0.000776	CcSEcCtD
Gatifloxacin—Bradycardia—Doxorubicin—urinary bladder cancer	0.000508	0.000774	CcSEcCtD
Gatifloxacin—Rash—Gemcitabine—urinary bladder cancer	0.000505	0.000769	CcSEcCtD
Gatifloxacin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000505	0.000768	CcSEcCtD
Gatifloxacin—Eye disorder—Epirubicin—urinary bladder cancer	0.000504	0.000768	CcSEcCtD
Gatifloxacin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000504	0.000767	CcSEcCtD
Gatifloxacin—Tinnitus—Epirubicin—urinary bladder cancer	0.000503	0.000766	CcSEcCtD
Gatifloxacin—Erythema—Methotrexate—urinary bladder cancer	0.000502	0.000765	CcSEcCtD
Gatifloxacin—Headache—Gemcitabine—urinary bladder cancer	0.000502	0.000764	CcSEcCtD
Gatifloxacin—Vomiting—Fluorouracil—urinary bladder cancer	0.000501	0.000763	CcSEcCtD
Gatifloxacin—Hepatitis—Doxorubicin—urinary bladder cancer	0.000499	0.00076	CcSEcCtD
Gatifloxacin—Rash—Fluorouracil—urinary bladder cancer	0.000497	0.000756	CcSEcCtD
Gatifloxacin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000496	0.000756	CcSEcCtD
Gatifloxacin—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000496	0.000755	CcSEcCtD
Gatifloxacin—Headache—Fluorouracil—urinary bladder cancer	0.000493	0.000751	CcSEcCtD
Gatifloxacin—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000492	0.000749	CcSEcCtD
Gatifloxacin—Dysgeusia—Methotrexate—urinary bladder cancer	0.000492	0.000749	CcSEcCtD
Gatifloxacin—Asthenia—Etoposide—urinary bladder cancer	0.000491	0.000747	CcSEcCtD
Gatifloxacin—Back pain—Methotrexate—urinary bladder cancer	0.000486	0.000739	CcSEcCtD
Gatifloxacin—Chills—Epirubicin—urinary bladder cancer	0.000484	0.000737	CcSEcCtD
Gatifloxacin—Pruritus—Etoposide—urinary bladder cancer	0.000484	0.000737	CcSEcCtD
Gatifloxacin—Visual impairment—Doxorubicin—urinary bladder cancer	0.000481	0.000733	CcSEcCtD
Gatifloxacin—Nausea—Gemcitabine—urinary bladder cancer	0.000476	0.000725	CcSEcCtD
Gatifloxacin—Vomiting—Cisplatin—urinary bladder cancer	0.000475	0.000723	CcSEcCtD
Gatifloxacin—Vision blurred—Methotrexate—urinary bladder cancer	0.000473	0.00072	CcSEcCtD
Gatifloxacin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000472	0.000719	CcSEcCtD
Gatifloxacin—Rash—Cisplatin—urinary bladder cancer	0.000471	0.000717	CcSEcCtD
Gatifloxacin—Dermatitis—Cisplatin—urinary bladder cancer	0.00047	0.000716	CcSEcCtD
Gatifloxacin—Erythema—Epirubicin—urinary bladder cancer	0.00047	0.000715	CcSEcCtD
Gatifloxacin—Diarrhoea—Etoposide—urinary bladder cancer	0.000468	0.000713	CcSEcCtD
Gatifloxacin—Nausea—Fluorouracil—urinary bladder cancer	0.000468	0.000712	CcSEcCtD
Gatifloxacin—Eye disorder—Doxorubicin—urinary bladder cancer	0.000467	0.000711	CcSEcCtD
Gatifloxacin—Tinnitus—Doxorubicin—urinary bladder cancer	0.000466	0.000709	CcSEcCtD
Gatifloxacin—Flatulence—Epirubicin—urinary bladder cancer	0.000463	0.000705	CcSEcCtD
Gatifloxacin—Tension—Epirubicin—urinary bladder cancer	0.000461	0.000702	CcSEcCtD
Gatifloxacin—Dysgeusia—Epirubicin—urinary bladder cancer	0.00046	0.000701	CcSEcCtD
Gatifloxacin—Nervousness—Epirubicin—urinary bladder cancer	0.000456	0.000695	CcSEcCtD
Gatifloxacin—Back pain—Epirubicin—urinary bladder cancer	0.000455	0.000692	CcSEcCtD
Gatifloxacin—Dizziness—Etoposide—urinary bladder cancer	0.000452	0.000689	CcSEcCtD
Gatifloxacin—Muscle spasms—Epirubicin—urinary bladder cancer	0.000452	0.000688	CcSEcCtD
Gatifloxacin—Vertigo—Methotrexate—urinary bladder cancer	0.000451	0.000687	CcSEcCtD
Gatifloxacin—Chills—Doxorubicin—urinary bladder cancer	0.000448	0.000682	CcSEcCtD
Gatifloxacin—Nausea—Cisplatin—urinary bladder cancer	0.000444	0.000675	CcSEcCtD
Gatifloxacin—Vision blurred—Epirubicin—urinary bladder cancer	0.000443	0.000674	CcSEcCtD
Gatifloxacin—Convulsion—Methotrexate—urinary bladder cancer	0.000435	0.000662	CcSEcCtD
Gatifloxacin—Vomiting—Etoposide—urinary bladder cancer	0.000435	0.000662	CcSEcCtD
Gatifloxacin—Erythema—Doxorubicin—urinary bladder cancer	0.000435	0.000662	CcSEcCtD
Gatifloxacin—Agitation—Epirubicin—urinary bladder cancer	0.000432	0.000657	CcSEcCtD
Gatifloxacin—Rash—Etoposide—urinary bladder cancer	0.000431	0.000657	CcSEcCtD
Gatifloxacin—Dermatitis—Etoposide—urinary bladder cancer	0.000431	0.000656	CcSEcCtD
Gatifloxacin—Headache—Etoposide—urinary bladder cancer	0.000429	0.000653	CcSEcCtD
Gatifloxacin—Flatulence—Doxorubicin—urinary bladder cancer	0.000428	0.000652	CcSEcCtD
Gatifloxacin—Chest pain—Methotrexate—urinary bladder cancer	0.000427	0.000651	CcSEcCtD
Gatifloxacin—Arthralgia—Methotrexate—urinary bladder cancer	0.000427	0.000651	CcSEcCtD
Gatifloxacin—Myalgia—Methotrexate—urinary bladder cancer	0.000427	0.000651	CcSEcCtD
Gatifloxacin—Tension—Doxorubicin—urinary bladder cancer	0.000427	0.00065	CcSEcCtD
Gatifloxacin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000426	0.000648	CcSEcCtD
Gatifloxacin—Nervousness—Doxorubicin—urinary bladder cancer	0.000422	0.000643	CcSEcCtD
Gatifloxacin—Vertigo—Epirubicin—urinary bladder cancer	0.000422	0.000643	CcSEcCtD
Gatifloxacin—Syncope—Epirubicin—urinary bladder cancer	0.000421	0.000642	CcSEcCtD
Gatifloxacin—Back pain—Doxorubicin—urinary bladder cancer	0.000421	0.00064	CcSEcCtD
Gatifloxacin—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000418	0.000636	CcSEcCtD
Gatifloxacin—Palpitations—Epirubicin—urinary bladder cancer	0.000415	0.000632	CcSEcCtD
Gatifloxacin—Confusional state—Methotrexate—urinary bladder cancer	0.000413	0.000629	CcSEcCtD
Gatifloxacin—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000413	0.000629	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00041	0.000624	CcSEcCtD
Gatifloxacin—Vision blurred—Doxorubicin—urinary bladder cancer	0.00041	0.000624	CcSEcCtD
Gatifloxacin—Convulsion—Epirubicin—urinary bladder cancer	0.000407	0.00062	CcSEcCtD
Gatifloxacin—Infection—Methotrexate—urinary bladder cancer	0.000407	0.00062	CcSEcCtD
Gatifloxacin—Nausea—Etoposide—urinary bladder cancer	0.000406	0.000619	CcSEcCtD
Gatifloxacin—Hypertension—Epirubicin—urinary bladder cancer	0.000406	0.000618	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000401	0.000611	CcSEcCtD
Gatifloxacin—Chest pain—Epirubicin—urinary bladder cancer	0.0004	0.000609	CcSEcCtD
Gatifloxacin—Myalgia—Epirubicin—urinary bladder cancer	0.0004	0.000609	CcSEcCtD
Gatifloxacin—Arthralgia—Epirubicin—urinary bladder cancer	0.0004	0.000609	CcSEcCtD
Gatifloxacin—Agitation—Doxorubicin—urinary bladder cancer	0.0004	0.000608	CcSEcCtD
Gatifloxacin—Anxiety—Epirubicin—urinary bladder cancer	0.000399	0.000607	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000396	0.000603	CcSEcCtD
Gatifloxacin—Vertigo—Doxorubicin—urinary bladder cancer	0.000391	0.000595	CcSEcCtD
Gatifloxacin—Anorexia—Methotrexate—urinary bladder cancer	0.000391	0.000595	CcSEcCtD
Gatifloxacin—Syncope—Doxorubicin—urinary bladder cancer	0.00039	0.000594	CcSEcCtD
Gatifloxacin—Confusional state—Epirubicin—urinary bladder cancer	0.000387	0.000589	CcSEcCtD
Gatifloxacin—Palpitations—Doxorubicin—urinary bladder cancer	0.000384	0.000585	CcSEcCtD
Gatifloxacin—Oedema—Epirubicin—urinary bladder cancer	0.000383	0.000584	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000383	0.000584	CcSEcCtD
Gatifloxacin—Hypotension—Methotrexate—urinary bladder cancer	0.000383	0.000583	CcSEcCtD
Gatifloxacin—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000382	0.000582	CcSEcCtD
Gatifloxacin—Infection—Epirubicin—urinary bladder cancer	0.000381	0.00058	CcSEcCtD
Gatifloxacin—Shock—Epirubicin—urinary bladder cancer	0.000377	0.000574	CcSEcCtD
Gatifloxacin—Convulsion—Doxorubicin—urinary bladder cancer	0.000377	0.000574	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000375	0.000572	CcSEcCtD
Gatifloxacin—Hypertension—Doxorubicin—urinary bladder cancer	0.000375	0.000572	CcSEcCtD
Gatifloxacin—Tachycardia—Epirubicin—urinary bladder cancer	0.000374	0.00057	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000373	0.000568	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000371	0.000564	CcSEcCtD
Gatifloxacin—Insomnia—Methotrexate—urinary bladder cancer	0.000371	0.000564	CcSEcCtD
Gatifloxacin—Chest pain—Doxorubicin—urinary bladder cancer	0.00037	0.000564	CcSEcCtD
Gatifloxacin—Arthralgia—Doxorubicin—urinary bladder cancer	0.00037	0.000564	CcSEcCtD
Gatifloxacin—Myalgia—Doxorubicin—urinary bladder cancer	0.00037	0.000564	CcSEcCtD
Gatifloxacin—Anxiety—Doxorubicin—urinary bladder cancer	0.000369	0.000562	CcSEcCtD
Gatifloxacin—Paraesthesia—Methotrexate—urinary bladder cancer	0.000368	0.00056	CcSEcCtD
Gatifloxacin—Anorexia—Epirubicin—urinary bladder cancer	0.000366	0.000557	CcSEcCtD
Gatifloxacin—Dyspnoea—Methotrexate—urinary bladder cancer	0.000365	0.000556	CcSEcCtD
Gatifloxacin—Somnolence—Methotrexate—urinary bladder cancer	0.000364	0.000555	CcSEcCtD
Gatifloxacin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000361	0.000549	CcSEcCtD
Gatifloxacin—Hypotension—Epirubicin—urinary bladder cancer	0.000358	0.000546	CcSEcCtD
Gatifloxacin—Confusional state—Doxorubicin—urinary bladder cancer	0.000358	0.000545	CcSEcCtD
Gatifloxacin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000356	0.000542	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000355	0.00054	CcSEcCtD
Gatifloxacin—Oedema—Doxorubicin—urinary bladder cancer	0.000355	0.00054	CcSEcCtD
Gatifloxacin—Infection—Doxorubicin—urinary bladder cancer	0.000353	0.000537	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000349	0.000532	CcSEcCtD
Gatifloxacin—Shock—Doxorubicin—urinary bladder cancer	0.000349	0.000532	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000347	0.000529	CcSEcCtD
Gatifloxacin—Insomnia—Epirubicin—urinary bladder cancer	0.000347	0.000528	CcSEcCtD
Gatifloxacin—Tachycardia—Doxorubicin—urinary bladder cancer	0.000346	0.000527	CcSEcCtD
Gatifloxacin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000344	0.000524	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000343	0.000522	CcSEcCtD
Gatifloxacin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000342	0.000521	CcSEcCtD
Gatifloxacin—Somnolence—Epirubicin—urinary bladder cancer	0.000341	0.000519	CcSEcCtD
Gatifloxacin—Anorexia—Doxorubicin—urinary bladder cancer	0.000338	0.000515	CcSEcCtD
Gatifloxacin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000338	0.000514	CcSEcCtD
Gatifloxacin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000338	0.000514	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000335	0.00051	CcSEcCtD
Gatifloxacin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000333	0.000508	CcSEcCtD
Gatifloxacin—Hypotension—Doxorubicin—urinary bladder cancer	0.000332	0.000505	CcSEcCtD
Gatifloxacin—Constipation—Epirubicin—urinary bladder cancer	0.000328	0.000499	CcSEcCtD
Gatifloxacin—Urticaria—Methotrexate—urinary bladder cancer	0.000326	0.000496	CcSEcCtD
Gatifloxacin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000324	0.000493	CcSEcCtD
Gatifloxacin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000324	0.000493	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000323	0.000492	CcSEcCtD
Gatifloxacin—Insomnia—Doxorubicin—urinary bladder cancer	0.000321	0.000489	CcSEcCtD
Gatifloxacin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000319	0.000485	CcSEcCtD
Gatifloxacin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000316	0.000482	CcSEcCtD
Gatifloxacin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000316	0.000481	CcSEcCtD
Gatifloxacin—Somnolence—Doxorubicin—urinary bladder cancer	0.000315	0.00048	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000314	0.000477	CcSEcCtD
Gatifloxacin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000312	0.000476	CcSEcCtD
Gatifloxacin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000308	0.00047	CcSEcCtD
Gatifloxacin—Urticaria—Epirubicin—urinary bladder cancer	0.000305	0.000464	CcSEcCtD
Gatifloxacin—Constipation—Doxorubicin—urinary bladder cancer	0.000303	0.000462	CcSEcCtD
Gatifloxacin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000303	0.000462	CcSEcCtD
Gatifloxacin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000303	0.000462	CcSEcCtD
Gatifloxacin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000302	0.00046	CcSEcCtD
Gatifloxacin—Asthenia—Methotrexate—urinary bladder cancer	0.000294	0.000448	CcSEcCtD
Gatifloxacin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000292	0.000445	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00029	0.000442	CcSEcCtD
Gatifloxacin—Pruritus—Methotrexate—urinary bladder cancer	0.00029	0.000441	CcSEcCtD
Gatifloxacin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000283	0.00043	CcSEcCtD
Gatifloxacin—Urticaria—Doxorubicin—urinary bladder cancer	0.000282	0.000429	CcSEcCtD
Gatifloxacin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000281	0.000427	CcSEcCtD
Gatifloxacin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000281	0.000427	CcSEcCtD
Gatifloxacin—Diarrhoea—Methotrexate—urinary bladder cancer	0.00028	0.000427	CcSEcCtD
Gatifloxacin—Asthenia—Epirubicin—urinary bladder cancer	0.000275	0.000419	CcSEcCtD
Gatifloxacin—Pruritus—Epirubicin—urinary bladder cancer	0.000271	0.000413	CcSEcCtD
Gatifloxacin—Dizziness—Methotrexate—urinary bladder cancer	0.000271	0.000413	CcSEcCtD
Gatifloxacin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000262	0.0004	CcSEcCtD
Gatifloxacin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000261	0.000398	CcSEcCtD
Gatifloxacin—Vomiting—Methotrexate—urinary bladder cancer	0.000261	0.000397	CcSEcCtD
Gatifloxacin—Rash—Methotrexate—urinary bladder cancer	0.000258	0.000393	CcSEcCtD
Gatifloxacin—Dermatitis—Methotrexate—urinary bladder cancer	0.000258	0.000393	CcSEcCtD
Gatifloxacin—Headache—Methotrexate—urinary bladder cancer	0.000257	0.000391	CcSEcCtD
Gatifloxacin—Asthenia—Doxorubicin—urinary bladder cancer	0.000255	0.000388	CcSEcCtD
Gatifloxacin—Dizziness—Epirubicin—urinary bladder cancer	0.000254	0.000386	CcSEcCtD
Gatifloxacin—Pruritus—Doxorubicin—urinary bladder cancer	0.000251	0.000382	CcSEcCtD
Gatifloxacin—Vomiting—Epirubicin—urinary bladder cancer	0.000244	0.000371	CcSEcCtD
Gatifloxacin—Nausea—Methotrexate—urinary bladder cancer	0.000243	0.000371	CcSEcCtD
Gatifloxacin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000243	0.00037	CcSEcCtD
Gatifloxacin—Rash—Epirubicin—urinary bladder cancer	0.000242	0.000368	CcSEcCtD
Gatifloxacin—Dermatitis—Epirubicin—urinary bladder cancer	0.000242	0.000368	CcSEcCtD
Gatifloxacin—Headache—Epirubicin—urinary bladder cancer	0.00024	0.000366	CcSEcCtD
Gatifloxacin—Dizziness—Doxorubicin—urinary bladder cancer	0.000235	0.000357	CcSEcCtD
Gatifloxacin—Nausea—Epirubicin—urinary bladder cancer	0.000228	0.000347	CcSEcCtD
Gatifloxacin—Vomiting—Doxorubicin—urinary bladder cancer	0.000226	0.000344	CcSEcCtD
Gatifloxacin—Rash—Doxorubicin—urinary bladder cancer	0.000224	0.000341	CcSEcCtD
Gatifloxacin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000224	0.00034	CcSEcCtD
Gatifloxacin—Headache—Doxorubicin—urinary bladder cancer	0.000222	0.000338	CcSEcCtD
Gatifloxacin—Nausea—Doxorubicin—urinary bladder cancer	0.000211	0.000321	CcSEcCtD
